Position in ALXO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$15,968,196
+$12,279,065 QoQ
Shares Held
7,964,188
+143.9% QoQ
Ownership
5.92%
of shares outstanding
% of Portfolio
1.06%
of 13F equity value
Holder Rank
#4
of 68 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALXO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Redmile Group, LLC holds $1,432,283,191 across 31 Biotechnology names. ALXO ranks #14 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SRRK |
Scholar Rock Holding Corp
|
9,066,621 | $445,715,088 | |
| 2 | KRYS |
Krystal Biotech, Inc.
|
673,505 | $173,979,811 | |
| 3 | STOK |
Stoke Therapeutics, Inc.
|
4,164,120 | $135,583,747 | |
| 4 | IMNM |
Immunome Inc.
|
5,558,885 | $121,572,814 | |
| 5 | NRIX |
Nurix Therapeutics, Inc.
|
7,732,808 | $119,858,524 | |
| 6 | ANNX |
Annexon, Inc.
|
14,549,768 | $80,605,714 | |
| 7 | RGNX |
REGENXBIO Inc.
|
4,368,804 | $36,610,577 | |
| 8 | STTK |
Shattuck Labs, Inc.
|
5,539,724 | $35,620,425 |
All Filings in ALXO
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,968,196 | 7,964,188 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,689,131 | 3,264,718 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,099,358 | 3,332,983 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,407,453 | 3,391,455 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,268,239 | 3,640,834 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,161,650 | 3,689,611 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,982,568 | 3,836,576 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $24,339,799 | 4,036,451 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $48,240,575 | 4,326,509 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $54,486,440 | 3,659,264 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,159,787 | 1,283,289 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,637,500 | 1,283,289 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,653,136 | 586,977 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,846,186 | 607,470 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,197,568 | 752,097 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,203,387 | 766,797 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $13,053,509 | 772,397 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $16,807,264 | 782,097 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $63,847,169 | 864,435 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $49,979,433 | 914,035 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $72,161,964 | 978,600 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $82,786,480 | 960,400 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $15,375,276 | 407,400 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||